MetaCap

C4 Therapeutics Insider Trades

NASDAQ: CCCCHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

3.16+0.31 (+10.88%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
1 · $22.20K
Shares bought / sold
0 / 10.00K
Net activity
Net selling $22,200

C4 Therapeutics insider activity

Over the last 12 months, C4 Therapeutics insiders reported 45 transactions on SEC Form 4: 0 open-market purchases and 1 sale. Insiders bought $0 and sold $22,200 worth of stock, for net insider selling of $22,200. The largest seller was REYNO LEONARD, with $22,200 in reported sales.

The most recent filing shows Anderson Kenneth Carl (Director) reporting a transaction in 3,662 shares at $3.14 on Oct 1, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put CCCC's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

CCCC insider transactions

C4 Therapeutics insider transactions
DateInsiderTypeSharesValueFiling
Oct 1, 2026GROGAN DONNA ROYDirectorAward4,618$14.50KForm 4
Oct 1, 2026Anderson Kenneth CarlDirectorAward3,662$11.50KForm 4
Sep 18, 2026Adams KendraChief Financial OfficerTax withholding2,775$9.41KForm 4
Sep 18, 2026Adams KendraChief Financial OfficerOption exercise6,250—Form 4
Jul 10, 2026REYNO LEONARDChief Medical OfficerTax withholding7,397$30.03KForm 4
Jul 10, 2026REYNO LEONARDChief Medical OfficerOption exercise15,325—Form 4
Jul 1, 2026GROGAN DONNA ROYDirectorAward3,341$14.50KForm 4
Jul 1, 2026Anderson Kenneth CarlDirectorAward2,650$11.50KForm 4
Jun 1, 2026Anderson Kenneth CarlDirectorOption exercise1,070$2.26KForm 4
Apr 1, 2026GROGAN DONNA ROYDirectorAward5,370$14.50KForm 4
Apr 1, 2026Anderson Kenneth CarlDirectorAward4,259$11.50KForm 4
Feb 15, 2026Hirsch AndrewPresident & CEOTax withholding9,057$17.12KForm 4
Feb 15, 2026Hirsch AndrewPresident & CEOOption exercise20,400—Form 4
Feb 14, 2026Schick KellyChief People OfficerTax withholding7,269$13.74KForm 4
Feb 14, 2026Schick KellyChief People OfficerOption exercise20,950—Form 4
Feb 14, 2026Adams KendraChief Financial OfficerTax withholding15,381$29.07KForm 4
Feb 14, 2026Adams KendraChief Financial OfficerOption exercise30,950—Form 4
Feb 14, 2026REYNO LEONARDChief Medical OfficerTax withholding16,579$31.33KForm 4
Feb 14, 2026REYNO LEONARDChief Medical OfficerOption exercise30,950—Form 4
Feb 14, 2026Mossler MarkChief Accounting OfficerTax withholding3,268$6.18KForm 4
Feb 14, 2026Mossler MarkChief Accounting OfficerOption exercise9,420—Form 4
Feb 14, 2026Hirsch AndrewPresident & CEOTax withholding39,154$74.00KForm 4
Feb 14, 2026Hirsch AndrewPresident & CEOOption exercise81,725—Form 4
Feb 14, 2026Mahaney PaigeChief Scientific OfficerTax withholding2,446$4.62KForm 4
Feb 14, 2026Mahaney PaigeChief Scientific OfficerOption exercise7,050—Form 4
Feb 14, 2026Boyle Scott NChief Business OfficerTax withholding7,269$13.74KForm 4
Feb 14, 2026Boyle Scott NChief Business OfficerOption exercise20,950—Form 4
Feb 13, 2026Schick KellyChief People OfficerTax withholding1,735$3.28KForm 4
Feb 13, 2026Schick KellyChief People OfficerOption exercise5,000—Form 4
Feb 13, 2026Schick KellyChief People OfficerAward200,000—Form 4
Feb 13, 2026Adams KendraChief Financial OfficerTax withholding1,863$3.52KForm 4
Feb 13, 2026Adams KendraChief Financial OfficerOption exercise3,750—Form 4
Feb 13, 2026Adams KendraChief Financial OfficerAward240,000—Form 4
Feb 13, 2026REYNO LEONARDChief Medical OfficerAward240,000—Form 4
Feb 13, 2026Mossler MarkChief Accounting OfficerAward56,980—Form 4
Feb 13, 2026Hirsch AndrewPresident & CEOAward700,000—Form 4
Feb 13, 2026Mahaney PaigeChief Scientific OfficerAward240,000—Form 4
Feb 13, 2026Boyle Scott NChief Business OfficerTax withholding1,735$3.28KForm 4
Feb 13, 2026Boyle Scott NChief Business OfficerOption exercise5,000—Form 4
Feb 13, 2026Boyle Scott NChief Business OfficerAward200,000—Form 4
Jan 16, 2026REYNO LEONARDChief Medical OfficerSale10,000$22.20KForm 4
Jan 2, 2026Anderson Kenneth CarlDirectorAward5,958$11.50KForm 4
Jan 2, 2026GROGAN DONNA ROYDirectorAward7,513$14.50KForm 4
Oct 28, 2025Mahaney PaigeChief Scientific OfficerTax withholding5,644$14.56KForm 4
Oct 28, 2025Mahaney PaigeChief Scientific OfficerOption exercise19,200—Form 4
Oct 1, 2025GROGAN DONNA ROYDirectorAward6,740$14.49KForm 4
Oct 1, 2025Anderson Kenneth CarlDirectorAward5,349$11.50KForm 4
Sep 18, 2025Adams KendraChief Financial OfficerTax withholding2,775$9.21KForm 4
Sep 18, 2025Adams KendraChief Financial OfficerOption exercise6,250—Form 4
Jul 10, 2025REYNO LEONARDChief Medical OfficerTax withholding7,382$14.69KForm 4
Jul 10, 2025REYNO LEONARDChief Medical OfficerTax withholding7,382$14.69KForm 4
Jul 10, 2025REYNO LEONARDChief Medical OfficerOption exercise15,325—Form 4
Jul 1, 2025GROGAN DONNA ROYDirectorAward9,609$14.51KForm 4
Jul 1, 2025Anderson Kenneth CarlDirectorAward7,616$11.50KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related